Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review

Ya Yuwen; Xue-jie Han; Wei-liang Weng; Xue-yao Zhao; Yu-qi Liu; Wei-qiang Li; Da-sheng Liu; Yan-ping Wang; Ai-ping Lu

doi:10.1007/s11655-016-2277-8

Your Location：

Home >

Browse articles >

Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review

Updated：2021-08-27

- Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review
- Chinese Journal of Integrative Medicine Vol. 24, Issue 7, Pages: 545-550(2018)
- Affiliations：
  
  1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences,Beijing,China
  2. Institute of Clinical Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences,Beijing,China
  3. Chinese Medicine College, Ningxia Medical University,Yinchuan,China
  4. School of Chinese Medicine, Hong Kong Baptist University,Hong Kong SAR,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81202846), the State Administration of Traditional Chinese Medicine [No.ZYYBZ-2013(PJ85)], China Academy of Chinese Medical Sciences (No. Z0292)
- DOI：10.1007/s11655-016-2277-8
  CLC：
- Published：2018，
  
  Published Online：9 December 2016，
Scan for full text
Yuwen, Y., Han, Xj., Weng, Wl. et al. Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review., Chin. J. Integr. Med. 24, 545–550 (2018). https://doi.org/10.1007/s11655-016-2277-8

Ya Yuwen, Xue-jie Han, Wei-liang Weng, et al. Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review. [J]. Chinese Journal of Integrative Medicine 24(7):545-550(2018)
Yuwen, Y., Han, Xj., Weng, Wl. et al. Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review., Chin. J. Integr. Med. 24, 545–550 (2018). https://doi.org/10.1007/s11655-016-2277-8 DOI：

Ya Yuwen, Xue-jie Han, Wei-liang Weng, et al. Appraisal of the Quality and Contents of Clinical Practice Guidelines for Hypertension Management in Chinese Medicine: A Systematic Review. [J]. Chinese Journal of Integrative Medicine 24(7):545-550(2018) DOI： 10.1007/s11655-016-2277-8.

摘要

To evaluate the quality and consistency of recommendations in the clinical practice guidelines (CPGs) for hypertension in Chinese medicine (CM). CM CPGs were identified from 5 electronic databases and hand searches through related handbooks published from January 1990 to December 2013. Three reviewers independently appraised the CPGs based on the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument

and compared the CPGs’ recommendations on CM syndrome pattern classification and treatment. Five CM CPGs for hypertension were included. The quality score of the evidence-based (EB) guideline was higher than those of the consensus-based with no explicit consideration of evidence-based (CB-EB) and the consensus-based (CB) guidelines. Three out of five patterns in the CPGs were recommended by the EB guideline. Tianma Gouteng Formula (天麻钩藤复方) in the EB guideline was recommended mostly for hypertension patients with pattern of ascendant hyperactivity of Gan (Liver)-yang and pattern of yin deficiency with yang hyperactivity in the CPGs. Acupuncture and massage were recommended for Grade I and Grade II hypertension with severe symptoms weakening the quality of life in the EB guideline. For Grade I and Grade II hypertension

CM could be used alone

while for Grade III hypertension

they should be used in combination with Western medicines. The quality of EB guideline was higher than those of CB and CB-EB CPGs in CM for hypertension and CM should be prescribed alone or combined with Western medicines based on the grade of hypertension.

Abstract

CM could be used alone

while for Grade III hypertension

关键词

hypertensionChinese Medicineclinical practice guidelinesystematic reviewsyndrome pattern

Keywords

hypertensionChinese Medicineclinical practice guidelinesystematic reviewsyndrome pattern

references

Scottish Intercollegiate Guidelines. Network. SIGN 50: A guideline developer’s handbook. Cited April 5, 2013. Online document at http://www.sign.ac.uk/guidelines/fulltext/50.

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–223.

Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008;371:1513–1518.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LV, Lzzo Jr JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:206–1252.

Xu H, Chen KJ. Complementary and alternative medicine: is it possible to be mainstream? Chin J Integr Med 2012;18:403–404.

Chen KJ, Hui KK, Lee MS, Xu H. The potential benefit of complementary/alternative medicine in cardiovascular diseases. Evid Based Complement Alternat Med (Epub 2012 Jun 18).

Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 2006;98:673–680.

Chen KJ. Clinical services of Chinese medicine. Chin J Integr Med 2008;14:163–164.

Chen KJ, Xu H. The integration of traditional Chinese medicine and Western medicine. Eur Rev 2003;11:225–235.

Wang J, Xiong XJ. Current situation and perspectives of clinical study in integrative medicine in China. Evid Based Complement Alternat Med (Epub 2012 Feb 21).

Shi NN, Han XJ, Yuwen Y, Wang LY, Lu AP. Adoption in China of clinical practice guidelines for Hypertension using traditional Chinese medical approaches: a literature review based on clinical studies. J Altern Complement Med 2013;19:1–8.

Song J, Chen KJ. Set clinical therapeutic guideline in traditional medicine urgently. Chin J Integr Tradit West Med (Chin) 2006;26:581–584.

Yuwen Y, Shi NN, Wang LY, Xie YM, Han XJ, Lu AP. Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China. Chin J Integr Med 2012;18:112–119.

Yuwen Y, Xu JL, Shi NN, Wagn LY, Han XJ, Wang YY, et al. Assessing the quality of the first batch of evidencebased clinical practice guidelines in traditional Chinese medicine. J Tradit Chin Med 2011;31:376–381.

AGREE Enterprise website. Appraisal of guidelines for research and evaluation (AGREE II) instrument. Cited Jan 19, 2013. Available at http://www.agreetrust.org/resourcecentre/agree-ii/(last accessed 15 February 2013).

Siering U, Eikermann M, Hausner E, Hoffmann-Eßer W, Neugebauer EA. Appraisal tools for clinical practice guidelines: a systematic review. PLoS One 2013;8:e82915.

Yuwen Y, Han XJ, Shi NN, Wang LY, Liao X, Zhong LD, et al. Appraisal of clinical practice guidelines for the management of rheumatoid arthritis in traditional Chinese medicine using the AGREE II instrument: a systematic review. Eu J Integr Med 2014;6:176–185.

Cruse H, Winiarek M, Marshburn J, Clark O, Djulbegovic B. Quality and methods of developing practice guidelines. BMC Health Serv Res 2002;2:1–73.

Cao HX, Wang YY. Clinical practice guideline in Chinese medicine for hypertension. In: Evidence-based guideline of clinical practice in Chinese internal medicine China. Beijing: China Press of Traditional Chinese Medicine; 2011:227–249.

China Association of Chinese Medicine. Hypertension. In: Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine disease of modern medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:63–66.

China Association of Chinese Medicine. Headache. In: Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine symptoms of modern medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:43–45.

China Association of Chinese Medicine. Xuan Yun. In: Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine symptoms of modern medicine. Beijing: China Press of Traditional Chinese Medicine; 2008:43–45.

State Food and Drug Administration. Guidelines for clinical researches of new traditional Chinese drugs on rheumatoid arthritis. In: Guideline for clinical researches of new traditional Chinese drugs. Beijing: Chinese Press of Medicine Science and Technology; 2002:73–77.

Gallardo CR, Rigau D, Irfan A, Ferrer A, Caylà JA, Bonfill X, et al. Quality of tuberculosis guidelines: urgent need for improvement. Int J Tuberc Lung Dis 2010;14:1045–1051.

Kinnunen-Amoroso M, Pasternack I, Mattila S, Parantainen A. Evaluation of the practice guidelines of Finnish institute of occupational health with AGREE instrument. Ind Health 2009;47:689–693.

Alonso-Coello P, Irfan A, Solà I, Gich I, Delgado-Noguera M, Rigau D, et al. The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 2010;19:e58.

Gorman SK, Chung MH, Slavik RS, Zed PJ, Wilbur K, Dhingra VK. A critical appraisal of the quality of critical care pharmacotherapy clinical practice guidelines and their strength of recommendations. Intensive Care Med 2010;36:1636–1643.

Antman EM, Lau J, Kupelnick B, Chalmers TC. A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992;268:240–248.

Mulrow CD. Systematic reviews: rationale for systematic reviews. BMJ 1994;309:597–599.

Xiong X, Yang X, Liu Y, Zhang Y, Wang P, Wang J. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertens Res 2013;36:570–579.

Wang J, Xiong X, Liu W. Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients. Evid Based Complement Alternat Med 2014;2014:418206.

Wang J, Xiong X. Evidence-based Chinese medicine for hypertension. Evid Based Complement Alternat Med 2013;2013:978398.

Dong DX, Yao SL, Yu N, Yang B. Systematic review and meta-analysis of Tianma Gouteng Yin combined with enalapril for essential hypertension. J Emerg Tradit Chin Med (Chin) 2011;20:762–764.

Wang LY, Chan KW, Yuwen Y, Shi NN, Han XJ, Lu AP. Expert consensus on the treatment of hypertension with Chinese patent medicines. Evid Based Complement Alternat Med (Epub 2013 Apr 3)

Tsai DS, Chang YS, Li TC, Peng WH. Prescription pattern of Chinese herbal products for hypertension in Taiwan: a population-based study. J Ethnopharmacol 2014;155:1534–1540.

Xiong X, Yang X, Liu W, Chu F, Wang P, Wang J. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evid Based Complement Alternat Med (Epub 2013 Jun 26).

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

A systematic review and meta-analysis of type 2 diabetes mellitus treatment based on the “three-typed syndrome differentiation” theory in Chinese medicine

Individual patient data meta-analysis is needed in Chinese medical research

Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials

Chronic intermittent hypoxia and hypertension: A review of systemic inflammation and Chinese Medicine

Efficacy of externally applied Chinese herbal drugs in treating psoriasis: A systematic review

Related Author

No data

Related Institution

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

China Academy of Chinese Medical Sciences

Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences

Department of Cardiovascular Disease, Xiyuan Hospital, China Academy of Chinese Medical Sciences

The First Hospital of Beijing University of Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰